Literature DB >> 2143211

An assay for the assessment of lipocortin 1 levels in human lung lavage fluid.

S F Smith1, N J Goulding, J L Godolphin, T D Tetley, C M Roberts, A Guz, R J Flower.   

Abstract

The physiological function of the lipocortins, proteins which are thought to be glucocorticoid-regulated, is unclear. An improved assay for lipocortins might help to elucidate their role. A rapid and specific sandwich enzyme-linked immunosorbent assay (ELISA) for lipocortin 1 with a working range of 1-2000 ng/ml and an interrun coefficient of variation of less than 10% is described and used in this pilot study to quantify human lipocortin 1 for the first time in acellular bronchoalveolar lavage fluid (BALF), and in media conditioned by BAL cells, from control patients and those with pulmonary sarcoidosis. Using this assay a statistically significant relationship, not previously observed in man, has been demonstrated between concentrations of lipocortin 1/ml of BALF and serum cortisol levels (n = 10, rs = 0.6939, P less than 0.05). Although lipocortin 1 levels in acellular BALF were the same in control and sarcoid patients, significantly more lipocortin 1 was released from sarcoid BAL cells in culture (median 21.6, range 8.1-45.4 ng lipocortin/10(6) cells/h in culture) than from control cells (2.5, 1.5-7.6 ng lipocortin/10(6) cells/h in culture). The possible clinical significance of these data is discussed, but remains to be established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143211     DOI: 10.1016/0022-1759(90)90241-m

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

1.  Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.

Authors:  Gareth S D Purvis; Fausto Chiazza; Jianmin Chen; Rodrigo Azevedo-Loiola; Lukas Martin; Dennis H M Kusters; Chris Reutelingsperger; Nikolaos Fountoulakis; Luigi Gnudi; Muhammed M Yaqoob; Massimo Collino; Christoph Thiemermann; Egle Solito
Journal:  Diabetologia       Date:  2017-10-30       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.